Additionally, the Hras and Braf genes, which are linked to oncogenesis [43, 44] and the latter considered a therapeutic target [45], were overexpressed in VAT of patients with obesity in our study. This evidence concerns the gene HRAS and obesity due to melanocortin 4 receptor deficiency.